We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$518B
AUM Growth
+$24.3B
Cap. Flow
-$1.52B
Cap. Flow %
-0.29%
Top 10 Hldgs %
29.53%
Holding
15,731
New
1,614
Increased
6,434
Reduced
5,866
Closed
1,611

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$555M
2
C icon
Citigroup
C
+$407M
3
MDT icon
Medtronic
MDT
+$401M
4
CMG icon
Chipotle Mexican Grill
CMG
+$392M
5
GILD icon
Gilead Sciences
GILD
+$362M

Sector Composition

Rank Sector Weight
1 Technology 3.02%
2 Healthcare 2.92%
3 Consumer Discretionary 2.17%
4 Financials 2.1%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALUR.WS
13651
DELISTED
Allurion Technologies Warrants
ALUR.WS
$2.7K ﹤0.01%
67,258
-2,428,801
-97% -$254K
FIACW
13652
DELISTED
Focus Impact Acquisition Corp. Warrant
FIACW
$2.7K ﹤0.01%
100,066
+3,036
+3% +$114
TOUR
13653
PUT
Tuniu
TOUR
$53.2M
$2.7K ﹤0.01%
190
NRGV icon
13654
PUT
Energy Vault
NRGV
$687M
$2.69K ﹤0.01%
+2,800
New +$2.82K
XOMA
13655
CALL
DELISTED
Xoma
XOMA
$2.65K ﹤0.01%
100
-900
-90% -$24.4K
IGTAW
13656
DELISTED
Inception Growth Acquisition Limited Warrants
IGTAW
$2.61K ﹤0.01%
65,135
+300
+0.5% +$25
FVCB icon
13657
CALL
FVCBankcorp
FVCB
$338M
$2.61K ﹤0.01%
+200
New +$2.35K
NMR icon
13658
CALL
Nomura Holdings
NMR
$28.7B
$2.61K ﹤0.01%
500
-4,000
-89% -$22.7K
LXFR icon
13659
PUT
Luxfer Holdings
LXFR
$457M
$2.59K ﹤0.01%
200
-2,100
-91% -$24.4K
ENZ
13660
CALL
DELISTED
Enzo Biochem, Inc.
ENZ
$2.58K ﹤0.01%
2,300
-31,700
-93% -$35.5K
GLSTR
13661
DELISTED
Global Star Acquisition, Inc. Right
GLSTR
$2.57K ﹤0.01%
19,803
-766
-4% -$108
CMCM
13662
CALL
Cheetah Mobile
CMCM
$103M
$2.56K ﹤0.01%
+600
New +$2.23K
SES icon
13663
CALL
SES AI
SES
$223M
$2.56K ﹤0.01%
4,000
-13,200
-77% -$13.8K
ELVN icon
13664
CALL
Enliven Therapeutics
ELVN
$4.31B
$2.55K ﹤0.01%
100
-3,500
-97% -$81.1K
QQQH
13665
PUT
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$387M
$2.55K ﹤0.01%
+50
New +$2.5K
PMVP icon
13666
PUT
PMV Pharmaceuticals
PMVP
$67.2M
$2.53K ﹤0.01%
1,700
+1,600
+1,600% +$2.47K
BLACR
13667
DELISTED
Bellevue Life Sciences Acquisition Corp. Rights
BLACR
$2.53K ﹤0.01%
24,283
-300
-1% -$40
PPBI
13668
CALL
DELISTED
Pacific Premier Bancorp
PPBI
$2.52K ﹤0.01%
100
-2,000
-95% -$49.9K
PPBI
13669
PUT
DELISTED
Pacific Premier Bancorp
PPBI
$2.52K ﹤0.01%
100
-500
-83% -$12.5K
LUNG icon
13670
CALL
Pulmonx
LUNG
$104M
$2.49K ﹤0.01%
300
-100
-25% -$724
DDL
13671
PUT
Dingdong
DDL
$523M
$2.48K ﹤0.01%
+700
New +$1.53K
XELA
13672
CALL
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$2.47K ﹤0.01%
+1,200
New +$2.63K
ANIK icon
13673
PUT
Anika Therapeutics
ANIK
$288M
$2.47K ﹤0.01%
100
-4,900
-98% -$127K
LYEL icon
13674
Lyell Immunopharma
LYEL
$342M
$2.45K ﹤0.01%
89
-13,697
-99% -$402K
EZRAW
13675
DELISTED
Reliance Global Series A Warrants
EZRAW
$2.44K ﹤0.01%
45,520
+23,325
+105% +$1.32K

Similar funds

Citadel Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citadel Advisors's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,611 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
  • Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
  • Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
  • Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
  • Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
  • Citadel Advisors opened 1,614 new positions and closed 1,611 in Q3 2024.
  • Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.